How Health Economics Drives Medtech Growth with Betty Tsai, President of Cardiology Services International

How Health Economics Drives Medtech Growth with Betty Tsai, President of Cardiology Services International

From Outcomes Rocket by Saul Marquez

June 9, 2026 · 12 min

About this episode

Betty Tsai discusses the importance of health economics in medtech growth and adoption strategies.

Health economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commercialization strategies. Speaking with Saul at the MedTech Innovator event, she highlights how health economics reveals the true cost of a patient journey, from initial admission through readmissions and long-term care. Betty explores how value-based care and CMS performance metrics are reshaping hospital revenue and influencing adoption decisions. She also discusses alternative reimbursement pathways, such as the New Technology Add-on Payment, and emphasizes that companies demonstrating both clinical and economic value are more attractive to providers and investors. Tune in and learn why proving economic value may be one of the most important steps in driving medtech adoption. Resources: Connect with and follow Betty Tsai on LinkedIn.

People in this episode

Host: Saul Marquez

Guest: Betty Tsai

Topics covered

  • health economics
  • medtech growth
  • value-based care
  • reimbursement strategies
  • hospital revenue

Keywords

  • health economics
  • medtech
  • reimbursement
  • value-based care
  • clinical value

Mentioned in this episode

Organizations: Cardiology Services International, CMS

More episodes of Outcomes Rocket

Explore listener stats, chart rankings, contacts and more on the Outcomes Rocket podcast page.